This company has been marked as potentially delisted and may not be actively trading. Intec Pharma (NTEC) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock NTEC Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period INDP stock touches 52-week low at $0.78 amid market challengesFebruary 12, 2025 | msn.comIndaptus Therapeutics reports Q3 EPS (32c) vs. (47c) last yearNovember 13, 2024 | markets.businessinsider.comFinTechOn 2024: FinTech Associations from 14 Asian Economies Sign MOU to Enhance Collaborations in Anti-FraudNovember 5, 2024 | finance.yahoo.comX4 Pharmaceuticals, Inc. (XFOR)September 21, 2024 | finance.yahoo.comINDP Indaptus Therapeutics, Inc.August 23, 2024 | seekingalpha.comBuy Rating Affirmed for Indaptus Therapeutics Amid Positive Decoy20 Clinical DevelopmentsAugust 13, 2024 | markets.businessinsider.comWill Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs InMay 14, 2024 | msn.comBuy Rating Affirmed for Indaptus Therapeutics Amid Promising Decoy20 Clinical AdvancementsMay 10, 2024 | markets.businessinsider.comBuy Rating Affirmed for Indaptus Therapeutics Amid Positive Clinical and Financial OutlookMarch 15, 2024 | markets.businessinsider.comBuy Rating Affirmed on Indaptus Therapeutics as Decoy20 Advances in Phase 1 with Promising DevelopmentsMarch 6, 2024 | markets.businessinsider.comStocks to Watch Today: RVNL,Glenmark Pharma, PB Fintech,Sula Vineyards and moreFebruary 18, 2024 | msn.comChhattisgarh education minister calls for expansion of central schools in the stateFebruary 2, 2024 | msn.comH.C. Wainwright Sticks to Its Buy Rating for Indaptus Therapeutics (INDP)August 15, 2023 | markets.businessinsider.comNGENF - NervGen Pharma Corp.June 15, 2023 | finance.yahoo.com10-Q: INDAPTUS THERAPEUTICS, INC.May 11, 2023 | marketwatch.comFibromyalgia Treatment Market Research | 2023-2030May 10, 2023 | marketwatch.comEarly Pregnancy Test Kit Market May Set Epic Growth Story Major Players – Abbott, Church & Dwight, SPD Swiss Precision Diagnostics GmbHMay 9, 2023 | marketwatch.comFibromyalgia Treatment Market Share, Size, Financial Summaries Analysis from 2023 to 2028May 4, 2023 | marketwatch.comFibromyalgia Treatment Market Share by 2031April 27, 2023 | marketwatch.comIntec Pharma Ltd (5NU.SG)April 24, 2023 | ca.finance.yahoo.comFibromyalgia Treatment Market Size, Share, Outlook and Forecast to 2031March 30, 2023 | marketwatch.comMaxim Group Reaffirms Their Buy Rating on Indaptus Therapeutics (INDP)March 18, 2023 | markets.businessinsider.comFibromyalgia Treatment Market Forecast: An Analysis of Industry Trends for 2023-2028March 2, 2023 | marketwatch.comGlobal Parkinson’s Disease Treatment Market Opportunities, Business Statistics Research Report 2030 By VMReportsFebruary 19, 2023 | marketwatch.comFibromyalgia Treatment Market Size 2023 With Over-All Dominated, Share Of Everywhere, Ease Of Access Of SolutionsFebruary 15, 2023 | marketwatch.comSyphilis Rapid Test Kit Market : Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2028January 30, 2023 | marketwatch.comFibromyalgia Treatment Market Industry Updates, New Opportunities, Major Strategies, And Forecast 2028January 23, 2023 | marketwatch.comWith 1.7% CAGR, Fibromyalgia Treatment Market 2023 Is Flourishing Around the World by 2028 | 116 Pages ReportDecember 29, 2022 | marketwatch.comFibromyalgia Treatment Market (New Report) to Witness A Pronounce Growth During 2023-2028 | 116 Pages ReportDecember 21, 2022 | marketwatch.comFibromyalgia Treatment Market Size in 2022 with Latest Report of 100 Pages & Business Forecast up to 2028 by Value Chain Analysis | No of Pages 100October 17, 2022 | marketwatch.comFibromyalgia Treatment Market Size and Share 2022 Analysis Report by Industry Trends, Drivers, Applications, Sale and Forecast to 2028August 28, 2022 | marketwatch.comWorld Holdings Co Ltd (2429)July 5, 2022 | investing.comBeroe Inc.: Beroe partners with Mintec to power its intelligence offering with market-leading commodity price dataJune 4, 2022 | finanznachrichten.deEXEL INDUSTRIES :2020-2021 Full-year results: Significant improvement in margins combined with a sharp reduction in debtDecember 18, 2021 | finanznachrichten.deDataiku Increases Commitment to the Japanese Market to Accelerate Everyday AI in JapanDecember 10, 2021 | yahoo.comGenetron earnings preview: what Wall Street is expectingDecember 1, 2021 | markets.businessinsider.comHere's what Wall Street expects from Cipher Pharmaceuticals's earningsNovember 12, 2021 | markets.businessinsider.comIntec Closes Merger with Decoy BiosystemsAugust 3, 2021 | finance.yahoo.comIntec Announces Expected Closing Date of Decoy MergerAugust 3, 2021 | finance.yahoo.comIntec Parent Shares Up 60%July 29, 2021 | marketwatch.comBRIEF-Intec Announces $30 Mln Private Placement Ahead Of Decoy MergerJuly 26, 2021 | msn.comIntec Pharma in $30 Million Private PlacementJuly 26, 2021 | marketwatch.comIntec Announces $30 Million Private Placement Ahead of Decoy MergerJuly 26, 2021 | finance.yahoo.comIntec Pharma Ltd. Ordinary Shares (NTEC)July 24, 2021 | nasdaq.com Get Intec Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for NTEC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NTEC Media Mentions By Week NTEC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NTEC News Sentiment▼0.000.92▲Average Medical News Sentiment NTEC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NTEC Articles This Week▼00▲NTEC Articles Average Week Get the Latest News and Ratings for NTEC and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Intec Pharma and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies PYRGF News NNVC News IBIO News NBY News AEON News MTNB News CPHI News NRBO News SPRB News OGEN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NTEC) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intec Pharma Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Intec Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
